The Claim
In adults with type 2 diabetes on thyroxine replacement, free T4 is weakly positively correlated with HDL cholesterol, TSH is weakly positively correlated with LDL cholesterol, and TSH is weakly negatively correlated with HDL cholesterol, but these correlations are not sufficiently strong to predict cardiovascular risk.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with type 2 diabetes taking thyroxine, small statistical links exist between thyroid hormone levels and cholesterol levels, but these links are too weak to be used for predicting heart disease risk.
See the scientific wording
In adults with type 2 diabetes on thyroxine replacement, free T4 shows a weak positive correlation with HDL cholesterol, and TSH shows a weak positive correlation with LDL cholesterol and a weak negative correlation with HDL cholesterol, but these associations are not strong enough to predict cardiovascular risk.
When thyroid hormone levels rise, the liver takes up more bad cholesterol from the blood and breaks it down into bile, while blood vessels relax and become less inflamed. This lowers bad cholesterol and slightly raises good cholesterol, but the changes are too small to reliably predict heart disease risk.
What the research says
1 studyIn people with type 2 diabetes taking thyroid medicine, slightly higher free T4 is linked to a tiny bit more good cholesterol, and higher TSH is linked to a tiny bit more bad cholesterol and less good cholesterol — but these links are so small they can’t tell us who’s at risk for heart problems.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.